Genetic testing for DICER1 germline pathogenic variants must be offered in all patients with DICER1-related conditions, such as PPB, cystic nephroma, SLCT, cervical embryonal rhabdomyosarcoma, and pituitary and pineal blastoma, with or without positive family history [10,13]. This evidence concerns the gene DICER1 and pleuropulmonary blastoma.